Categories: World News

Texas Devices (TXN) inventory falls on weak forecast

The Texas Instruments headquarters in Dallas, Texas, on Jan. 21, 2024.

N. Johnson | Bloomberg | Getty Images

Texas Instruments reported second-quarter results on Tuesday that beat analysts’ expectations for revenue and earnings. But the stock fell in extended trading due to a third-quarter forecast that missed estimates.

Here’s how the chipmaker did versus LSEG consensus estimates:

  • Earnings per share: $1.41 vs. $1.35 expected
  • Revenue: $4.45 billion vs. $4.36 billion expected

Texas Instruments said it expects current-quarter earnings between $1.36 and $1.60 per share, while analysts were looking for $1.50 per share. The company forecast revenue of $4.45 billion to $4.8 billion, for a midpoint of $4.625 billion. Analysts were expecting revenue of $4.59 billion.

Revenue increased 16% in the second quarter from $3.82 billion in the same period a year earlier. Sales in the company’s analog chip business, its largest, rose 18% to $3.5 billion, surpassing the StreetAccount estimate of $3.39 billion for the segment.

Net income rose 15% to $1.3 billion, or $1.41 per share, from $1.13 billion, or $1.22 per share, a year ago.

Texas Instruments is a key supplier of legacy semiconductors for automotive and industrial uses.

As of Tuesday’s close, Texas Instruments shares were up 15% for the year on broader market optimism for chips. In June, the company said it would spend $60 billion to expand chipmaking factories in Texas and Utah, a move that was praised by the Trump administration in its push to bring more technology manufacturing to the U.S.

Don’t miss these insights from CNBC PRO

Greg Abbott

Greg Abbott has been a well-reviewed and sought after Author and Political Writer for 20+ years by his peers, Editors, and Publishers. Greg is an exceptionally proficient as a long form Author, Ghost Writer, as well as an online blogger. Abbott is well known Internationally as an authority in United States public policy and American Politics.

Recent Posts

Eli Lilly shares slide after bearish analyst name – this is our take

Shares of Eli Lilly fell 6% on Tuesday and are on track for their worst…

18 hours ago

In a disastrous press convention, Trump exhibits how he misplaced the Iran warfare

The White House described Trump's press conference with Vice President JD Vance as evidence that…

1 day ago

Oscars 2026 after-parties: celeb photographs, style

The 2026 Oscars may be over, but film's biggest night continues. After One Battle After…

2 days ago

Hegseth dismisses issues concerning the Strait of Hormuz in gentle of the Iran battle

Defense Secretary Pete Hegseth brushed aside concerns Friday that the actual closure of the Strait…

3 days ago

Die Zölle der US-Bundesstaaten steigen, da Trump während der Halbzeitwahlen mit einem Kampf um die Erschwinglichkeit konfrontiert ist

Eine neue Analyse der US-Volkszählungsdaten zeigt, dass Bundesstaaten in den USA, in denen in diesem…

4 days ago

The Vertex kidney drug povetacicept is profitable within the examine for IgAN

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder…

5 days ago

This website uses cookies.